AzTrials
AzTrials

Children With Motor ImpairmentsNCT07109830

Utilizing an EEG-Based BCI Game to Evaluate Cognitive Skills in Children With Motor Impairments

An observational study of Children With Motor Impairments, run by University of Alberta at 2 sites in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This project aims to validate an EEG-based brain-computer interface (BCI) game as a cognitive assessment tool for children with motor impairments. Traditional cognitive assessments often rely on motor responses, which may underestimate the abilities of children with limited mobility. Read more about this study

Who is it for?
Ages 7 to 16 years
Conditions the study is for
Children With Motor Impairments
What is being tested?
Cognitive assessment and NEPSY-II
How many people
73 participants
Where
2 sitesCanada
Study dates
11 Nov 2025to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 16 years
  • All sexes
  • Child

Study population: Typically developing children and children with motor impairments

Who may be able to join

  • Children with and without motor impairments.
  • Ages 7-16.
  • Understand simple commands

Who cannot join

  • Vision impairment

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Munirah Alsubaie contact

7809204861

malsubai@ualberta.ca

Canada2 sites, 2 recruiting
  • University of Alberta

    Edmonton, Alberta, T6G 2B9

    Adriana Rios Rincon, 7802248685, aros@ualberta.ca

    Not yet recruiting
  • University of Alberta

    Edmonton, Alberta

    PhD Candidate, 7809204861, malsubai@ualberta.ca

    Recruiting

Other trials in Canada

About this study

Official title: Utilizing an Electroencephalography-Based Brain-Computer Interface Game to Evaluate Cognitive Skills in Children With Motor Impairments

This project aims to validate an EEG-based brain-computer interface (BCI) game as a cognitive assessment tool for children with motor impairments. Traditional cognitive assessments often rely on motor responses, which may underestimate the abilities of children with limited mobility. By using BCI technology, which captures brain activity directly, the study seeks to bypass these limitations and offer a more inclusive, engaging, and accurate assessment method.

The research consists of three papers:

Read more
  1. Pilot Study: Tests the feasibility of the BCI game, comparing BCI and keyboard controls, and examines alignment with NEPSY-II cognitive subtests.
  2. Validation Study: Investigates the convergent validity of the BCI game in typically developing children by correlating game performance with standardized cognitive test scores.
  3. Adaptation Study: Compares game performance between neurotypical children and children with motor impairments to evaluate the game's inclusivity and adaptability.

The project utilizes the Emotiv Flex 2 EEG system and focuses on cognitive domains such as attention, working memory, and inhibition. The ultimate goal is to develop a reliable, equitable tool for assessing cognition in children with diverse motor abilities.

Being tested
Cognitive assessment, NEPSY-II

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive assessmentDiagnostic test

    Cognitive assessment using BCI-game

  • NEPSY-IIDiagnostic test

    Standardized cognitive assessment

Study groups in NCT07109830
Study groupRoleWhat they receive
Typically developing childrenNot described
Receives: Diagnostic Test: Cognitive assessment; Diagnostic Test: NEPSY-II
Children with motor impairmentsNot described
Receives: Diagnostic Test: Cognitive assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neuropsychological assessment (NEPSY-II)

    The NEPSY-II (A Developmental Neuropsychological Assessment, Second Edition) is a standardized cognitive assessment for children aged 3-16 years. It evaluates multiple domains of cognitive functioning, including Attention and Executive Functioning, Memory and Learning, and Visuospatial Processing. Each subtest yields a scaled score ranging from 1 to 19 (mean = 10, SD = 3) and domain-level standard scores (mean = 100, SD = 15). Higher scores indicate better cognitive performance.

    Measured: "Baseline (Day 1): NEPSY-II will be administered during the single study session at the same visit as the BCI game."

  2. BCI game metrics

    The BCI-controlled adventure-style game is designed to assess cognitive domains including attention, working memory, and inhibitory control. Participants navigate a virtual environment by turning left or right using brain-computer interface control based on steady-state visually evoked potentials (SSVEP).

    Coins collected reflect the participant's sustained attention and working memory by requiring consistent focus and memory of task-specific rules (e.g., avoiding certain coin colors).

    Obstacles avoided reflect inhibitory control by requiring participants to suppress automatic responses and adapt to changing task demands.

    Each metric is a count variable (0-maximum possible in the game), where higher values indicate better cognitive performance.

    Measured: Baseline (Day 1; during the single study visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2025
  2. Study start11 Nov 2025
  3. Primary completionAug 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
73 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07109830
Sponsor's protocol ID
Pro00153206
Status last verified
Nov 2025
First submitted
21 Jul 2025
Last updated
7 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Only people working on this project will have access to identifiable information and it will be store in an encrypted file

Questions about this trial

What is this clinical trial studying?

An observational study of Children With Motor Impairments, run by University of Alberta at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Munirah Alsubaie (7809204861, malsubai@ualberta.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neuropsychological assessment (NEPSY-II) (time frame: "Baseline (Day 1): NEPSY-II will be administered during the single study session at the same visit as the BCI game."). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in